Menu

Image of the Day: Roses Are Red, Poppies Are Too

New research shows how they get their deep hue.

Feb 14, 2019
Carolyn Wilke
The cells in a poppy’s petals look like tiny jigsaw pieces.
UNIVERSITY OF GRONINGEN

A poppy’s petals are tissue-thin, yet so intensely colored because their cells are loaded with pigment and interact with light in a particular way, researchers reported January 28 in the Journal of Comparative Physiology A.

The petals are formed of three layers, with pigment-containing cells sandwiching a layer that lacks pigment. Using microscopy, the researchers zoomed in on the petals to find tiny pieces of a jigsaw puzzle. Gaps of air sit between the puzzle piece cells, resulting in the reflection of light at cell boundaries that creates strong light scattering. 

The cells are also packed with high concentrations of pigment. In fact, markings that appear black at the center of some poppies actually result from extremely concentrated red pigment, according to the authors. 

C.J. van der Kooi, D.G. Stavenga, “Vividly coloured poppy flowers due to dense pigmentation and strong scattering in thin petals,” Journal of Comparative Physiology A, doi:10.1007/s00359-018-01313-1, 2019.

Poppies of several varieties were used in the study. Clockwise from top left: Papaver rhoeas, P. dubium, Meconopsis cambrica orange, M. cambrica yellow
UNIVERSITY OF GRONINGEN

March 2019

Going Under

Dissecting the effects of anesthetics

Marketplace

Sponsored Product Updates

The Complex Biology of Macrophages: Origins, Functions, and Activation States
The Complex Biology of Macrophages: Origins, Functions, and Activation States
Download this poster from R&D Systems for a detailed overview of macrophage markers, functions, development, specialization, and activation!
A Guide to Measuring Drug-Target Residence Times with Biochemical Assays
A Guide to Measuring Drug-Target Residence Times with Biochemical Assays
Download this guide from BellBrook Labs to learn about how to use Transcreener® biochemical assays to measure drug-target residence times, complete with examples and case studies!
Beckman Coulter Life Sciences To Launch New Product Via Live Stream Event
Beckman Coulter Life Sciences To Launch New Product Via Live Stream Event
After visiting labs around the world to identify ways to advance its industry-leading cell counting technology, Beckman Coulter Life Sciences will host a live streaming event on March 26 at 10 a.m. EDT / 7 a.m. PDT to announce its latest product innovation.  
Cybrexa Therapeutics to Present First Data and Unveil Details for its alphalex™-PARP Inhibitor Lead Candidate CBX-11 at AACR Annual Meeting 2019
Cybrexa Therapeutics to Present First Data and Unveil Details for its alphalex™-PARP Inhibitor Lead Candidate CBX-11 at AACR Annual Meeting 2019
Cybrexa Therapeutics, a biotechnology company developing a new class of cancer therapeutics through its alphalex™ tumor targeting platform, today announced that Vishwas Paralkar, PhD, Chief Scientific Officer of Cybrexa, will present the first set of preclinical data supporting its alphalex™-PARP inhibitor lead candidate, CBX-11, at the American Association for Cancer Research (AACR) Annual Meeting 2019, being held March 29 – April 3 in Atlanta, Georgia. At the meeting, the Company will unveil the FDA-approved poly ADP-ribose polymerase (PARP) inhibitor conjugated in CBX-11.